ANAB logo

AnaptysBio (ANAB) CAPEX

Annual CAPEX

$358.00 K
-$449.00 K-55.64%

December 31, 2024

Summary

Performance

1-Year Change

-55.64%

3-Year Change

-73.79%

5-Year Change

-55.53%

15-Year Change

+23.45%

ANAB CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.66%
ANAB annual capital expenditures is higher than 24.66% of companies in Healthcare sector

High & Low

All-time High

$1.37 M
ANAB annual capital expenditures is currently -73.79% below its historical high of $1.37 million

3-Year Low

$358.00 K
ANAB annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ANAB previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ANAB next annual earnings announcement has not yet been scheduled

OtherANABcash flowmetrics:

Annual FCF

-$135.69 M
ANAB annual free cash flow is -$135.69 million

Annual CFO

-$135.34 M
ANAB annual cash flow from operations is -$135.34 million

Annual CFI

$95.40 M
ANAB annual cash flow from investing activities is $95.40 million

Annual CFF

$127.05 M
ANAB annual cash flow from financing activities is $127.05 million

Quarterly CAPEX

$263.00 K
+$228.00 K+651.43%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+1778.57%

5-Year Change

+152.88%

ANAB Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.03%
ANAB quarterly capital expenditures is higher than 40.03% of companies in Healthcare sector

High & Low

All-time High

$863.00 K
ANAB quarterly capital expenditures is currently -69.52% below its historical high of $863.00 thousand

3-Year Low

$14.00 K
ANAB quarterly capital expenditures is currently +1778.57% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ANAB previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ANAB next earnings announcement is scheduled for May 9, 2025

OtherANABcash flowmetrics:

Quarterly FCF

-$66.94 M
ANAB quarterly free cash flow is -$66.94 million

Quarterly CFO

-$66.67 M
ANAB quarterly cash flow from operations is -$66.67 million

Quarterly CFI

-$29.40 M
ANAB quarterly cash flow from investing activities is -$29.40 million

Quarterly CFF

$27.57 M
ANAB quarterly cash flow from financing activities is $27.57 million

TTM CAPEX

$358.00 K
-$17.00 K-4.53%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-73.79%

5-Year Change

-55.53%

ANAB TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.41%
ANAB TTM capital expenditures is higher than 21.41% of companies in Healthcare sector

High & Low

All-time High

$1.66 M
ANAB TTM capital expenditures is currently -78.47% below its historical high of $1.66 million

3-Year Low

$197.00 K
ANAB TTM capital expenditures is currently +81.73% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ANAB previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ANAB next earnings announcement is scheduled for May 9, 2025

OtherANABcash flowmetrics:

TTM FCF

-$135.69 M
ANAB TTM free cash flow is -$135.69 million

TTM CFO

-$135.34 M
ANAB TTM cash flow from operations is -$135.34 million

TTM CFI

$95.40 M
ANAB TTM cash flow from investing activities is $95.40 million

TTM CFF

$127.05 M
ANAB TTM cash flow from financing activities is $127.05 million

ANAB CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-55.6%0.0%0.0%
3 y3 years-73.8%+1778.6%-73.8%
5 y5 years-55.5%+152.9%-55.5%

ANAB CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-73.8%at low-6.1%+1778.6%-73.8%+81.7%
5 y5-year-73.8%at low-69.5%+1778.6%-78.5%+81.7%
alltimeall time-73.8%+867.6%-69.5%-100.0%-78.5%+616.0%

AnaptysBio CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
$358.00 K(-55.6%)
$263.00 K(+651.4%)
$358.00 K(-4.5%)
Sep 2024
-
$35.00 K(+6.1%)
$375.00 K(-25.3%)
Jun 2024
-
$33.00 K(+22.2%)
$502.00 K(-23.8%)
Mar 2024
-
$27.00 K(-90.4%)
$659.00 K(-18.3%)
Dec 2023
$807.00 K(+125.4%)
$280.00 K(+72.8%)
$807.00 K(+15.0%)
Sep 2023
-
$162.00 K(-14.7%)
$702.00 K(+19.0%)
Jun 2023
-
$190.00 K(+8.6%)
$590.00 K(+23.4%)
Mar 2023
-
$175.00 K(0.0%)
$478.00 K(+33.5%)
Dec 2022
$358.00 K(-73.8%)
$175.00 K(+250.0%)
$358.00 K(+81.7%)
Sep 2022
-
$50.00 K(-35.9%)
$197.00 K(-38.2%)
Jun 2022
-
$78.00 K(+41.8%)
$319.00 K(-71.1%)
Mar 2022
-
$55.00 K(+292.9%)
$1.10 M(-19.2%)
Dec 2021
$1.37 M(+140.1%)
$14.00 K(-91.9%)
$1.37 M(-17.9%)
Sep 2021
-
$172.00 K(-80.1%)
$1.66 M(+5.3%)
Jun 2021
-
$863.00 K(+172.2%)
$1.58 M(+97.6%)
Mar 2021
-
$317.00 K(+1.9%)
$799.00 K(+40.4%)
Dec 2020
$569.00 K(-29.3%)
$311.00 K(+253.4%)
$569.00 K(+57.2%)
Sep 2020
-
$88.00 K(+6.0%)
$362.00 K(-34.7%)
Jun 2020
-
$83.00 K(-4.6%)
$554.00 K(-22.2%)
Mar 2020
-
$87.00 K(-16.3%)
$712.00 K(-11.6%)
Dec 2019
$805.00 K
$104.00 K(-62.9%)
$805.00 K(-11.2%)
DateAnnualQuarterlyTTM
Sep 2019
-
$280.00 K(+16.2%)
$907.00 K(-4.3%)
Jun 2019
-
$241.00 K(+33.9%)
$948.00 K(-6.2%)
Mar 2019
-
$180.00 K(-12.6%)
$1.01 M(-4.9%)
Dec 2018
$1.06 M(+266.6%)
$206.00 K(-35.8%)
$1.06 M(+8.4%)
Sep 2018
-
$321.00 K(+5.6%)
$981.00 K(+45.8%)
Jun 2018
-
$304.00 K(+31.0%)
$673.00 K(+54.0%)
Mar 2018
-
$232.00 K(+87.1%)
$437.00 K(+50.7%)
Dec 2017
$290.00 K(+480.0%)
$124.00 K(+853.8%)
$290.00 K(+73.7%)
Sep 2017
-
$13.00 K(-80.9%)
$167.00 K(+8.4%)
Jun 2017
-
$68.00 K(-20.0%)
$154.00 K(+54.0%)
Mar 2017
-
$85.00 K(+8400.0%)
$100.00 K(+100.0%)
Dec 2016
$50.00 K(-79.0%)
$1000.00(>+9900.0%)
$50.00 K(-45.1%)
Sep 2016
-
$0.00(-100.0%)
$91.00 K(-48.0%)
Jun 2016
-
$14.00 K(-60.0%)
$175.00 K(-9.3%)
Mar 2016
-
$35.00 K(-16.7%)
$193.00 K(-18.9%)
Dec 2015
$238.00 K(+64.1%)
$42.00 K(-50.0%)
$238.00 K(+21.4%)
Sep 2015
-
$84.00 K(+162.5%)
$196.00 K(+75.0%)
Jun 2015
-
$32.00 K(-60.0%)
$112.00 K(+40.0%)
Mar 2015
-
$80.00 K
$80.00 K
Dec 2014
$145.00 K(+291.9%)
-
-
Dec 2013
$37.00 K
-
-

FAQ

  • What is AnaptysBio annual capital expenditures?
  • What is the all time high annual CAPEX for AnaptysBio?
  • What is AnaptysBio annual CAPEX year-on-year change?
  • What is AnaptysBio quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for AnaptysBio?
  • What is AnaptysBio quarterly CAPEX year-on-year change?
  • What is AnaptysBio TTM capital expenditures?
  • What is the all time high TTM CAPEX for AnaptysBio?
  • What is AnaptysBio TTM CAPEX year-on-year change?

What is AnaptysBio annual capital expenditures?

The current annual CAPEX of ANAB is $358.00 K

What is the all time high annual CAPEX for AnaptysBio?

AnaptysBio all-time high annual capital expenditures is $1.37 M

What is AnaptysBio annual CAPEX year-on-year change?

Over the past year, ANAB annual capital expenditures has changed by -$449.00 K (-55.64%)

What is AnaptysBio quarterly capital expenditures?

The current quarterly CAPEX of ANAB is $263.00 K

What is the all time high quarterly CAPEX for AnaptysBio?

AnaptysBio all-time high quarterly capital expenditures is $863.00 K

What is AnaptysBio quarterly CAPEX year-on-year change?

Over the past year, ANAB quarterly capital expenditures has changed by $0.00 (0.00%)

What is AnaptysBio TTM capital expenditures?

The current TTM CAPEX of ANAB is $358.00 K

What is the all time high TTM CAPEX for AnaptysBio?

AnaptysBio all-time high TTM capital expenditures is $1.66 M

What is AnaptysBio TTM CAPEX year-on-year change?

Over the past year, ANAB TTM capital expenditures has changed by $0.00 (0.00%)